Respiratory

Adults with psoriasis may be more likely to also have chronic bronchitis, according to new U.S. population-based findings.

Severe Legionnaires’ disease requiring intensive care unit (ICU) admission shows improved survival compared to earlier reports, according to a multicenter retrospective cohort study of French patients.

Rheumatoid arthritis associated interstitial lung disease (RA-ILD) is increasingly recognized as a major factor influencing long-term outcomes in affected patients, with new data showing that disease progression and specific lung patterns significantly impact mortality.

The addition of nivolumab to platinum-etoposide chemotherapy improved both progression-free and overall survival in patients with extensive-stage small cell lung cancer (ES-SCLC), according to results from the randomized Phase II ECOG-ACRIN EA5161 trial.

Emotional distress before treatment is strongly associated with poorer responses to immunotherapy in patients with advanced non-small cell lung cancer (NSCLC), according to new research.

The availability of elexacaftor–tezacaftor–ivacaftor (ETI) has been associated with a marked reduction in cystic fibrosis liver disease (CFLD) progression, according to a nationwide analysis.

Children from disadvantaged neighborhoods face a sharper increase in viral-associated asthma exacerbations when returning to school after summer, according to a new population-based analysis.

A Parkinson’s disease medication has demonstrated potent activity against Mycobacterium tuberculosis through a novel host-directed mechanism, offering a potential new avenue for combating the disease and addressing antimicrobial resistance.